For San Diego researchers and the wider immunotherapy community, the atlas functions as a practical roadmap. It does not ...
A multi-institutional study led by researchers at the Salk Institute for Biological Studies, UNC Lineberger Comprehensive ...
A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine ...
They discovered that an ongoing viral infection causes a brief but striking shift in the availability of nutrients in the ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
CHAPEL HILL, N.C. - Feb. 4, 2026 - A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute ...
This image shows killer T cells surrounding and attacking a cancer cell. A new atlas developed by researchers at UC San Diego could make it possible to design custom T cells for immunotherapy to ...
The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...
Patients with advanced non-small cell lung cancer who received immunochemotherapy in the morning or early afternoon had ...
First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...
Research Highlights Gut Microbiome’s Role in Cancer Defense Mechanisms Gut Bacteria May Decide Whether a Dietary Amino Acid ...
Bria-IMT demonstrates a median overall survival of 15.6 months, surpassing historical data for heavily pretreated metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results